Chembio Diagnostics (CEMI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2005 | 03-2005 | 12-2004 | 09-2004 | 06-2004 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,495 | -620 | -3,099 | -2,206 | -1,147 |
| Depreciation Amortization | 39 | 16 | 110 | 99 | 75 |
| Accounts receivable | -118 | -101 | 119 | 121 | -26 |
| Other Working Capital | -298 | -314 | -298 | -809 | -615 |
| Other Operating Activity | 115 | 99 | 520 | 403 | 538 |
| Operating Cash Flow | $-1,756 | $-920 | $-2,648 | $-2,392 | $-1,174 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -240 | -86 | -61 | -67 | -47 |
| Investing Cash Flow | $-240 | $-86 | $-61 | $-67 | $-47 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 162 | 162 | 295 | 976 | 926 |
| Debt Repayment | -28 | -14 | -123 | -99 | -97 |
| Common Stock Issued | 25 | N/A | 361 | N/A | N/A |
| Other Financing Activity | 4,459 | 4,519 | 2,210 | 1,865 | 1,865 |
| Financing Cash Flow | $4,618 | $4,667 | $2,743 | $2,742 | $2,694 |
| Beginning Cash Position | 35 | 35 | N/A | N/A | N/A |
| End Cash Position | 2,657 | 3,697 | 35 | 283 | 1,472 |
| Net Cash Flow | $2,622 | $3,662 | $35 | $283 | $1,472 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,756 | -920 | -2,648 | -2,392 | -1,174 |
| Capital Expenditure | -240 | -86 | -61 | -67 | -47 |
| Free Cash Flow | -1,996 | -1,005 | -2,708 | -2,460 | -1,222 |